# Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

> **NCT03628144** · PHASE2 · WITHDRAWN · sponsor: **H. Lee Moffitt Cancer Center and Research Institute**

## Conditions studied

- Non Small Cell Lung Cancer
- NSCLC
- Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer Stage IIIB
- Non-small Cell Lung Cancer Stage ⅢA
- NSCLC Stage IIIB
- NSCLC, Stage IIIA

## Interventions

- **DIETARY_SUPPLEMENT:** Impact® Advanced Recovery
- **DIETARY_SUPPLEMENT:** Boost® High Protein
- **RADIATION:** Radiation Therapy
- **DRUG:** Chemotherapy
- **OTHER:** Quality of life (EORTC-QLQ-30)
- **OTHER:** Evaluation of Cognitive Function (FACT-Cog, v. 3.0)
- **OTHER:** Mindfulness Questionnaire (FFMQ)

## Key facts

- **NCT ID:** NCT03628144
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-07
- **Primary completion:** 2022-09
- **Final completion:** 2023-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding unavailable
- **Last updated:** 2020-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628144, "Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03628144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*